Compound Q&A
What is the market or research trend for Alpelisib (CAS: 1217486-61-7)?
Answer
Alpelisib (CAS: 1217486-61-7) has a growing market trend, particularly in oncology due to its role as a selective phosphoinositide 3-kinase (PI3K) inhibitor. Research is expanding into new clinical trials and studies, focusing on its efficacy in treating certain types of breast and ovarian cancer. Market trends indicate increasing demand as more therapeutic applications are explored.
About
CAS No
1217486-61-7
English Name
Alpelisib
Molecular Formula
C19H22F3N5O2S
Molecular Weight
441.4790000000001 g/mol
SMILES
Cc1nc(NC(=O)N2CCC[C@H]2C(=O)N)sc1c3ccnc(c3)C(C)(C)C(F)(F)F
InChIKey
STUWGJZDJHPWGZ-LBPRGKRZSA-N
Last Updated: 2025-09-08 18:31
